4.6 Article

An Essential Role for Diet in Exercise-Mediated Protection against Dyslipidemia, Inflammation and Atherosclerosis in ApoE-/- Mice

Journal

PLOS ONE
Volume 6, Issue 2, Pages -

Publisher

PUBLIC LIBRARY SCIENCE
DOI: 10.1371/journal.pone.0017263

Keywords

-

Funding

  1. National Institutes of Health [HL092499]

Ask authors/readers for more resources

Background: Diet and exercise promote cardiovascular health but their relative contributions to atherosclerosis are not fully known. The transition from a sedentary to active lifestyle requires increased caloric intake to achieve energy balance. Using atherosclerosis-prone ApoE-null mice we sought to determine whether the benefits of exercise for arterial disease are dependent on the food source of the additional calories. Methods and Results: Mice were fed a high-fat diet (HF) for 4.5 months to initiate atherosclerosis after which time half were continued on HF while the other half were switched to a high protein/fish oil diet (HP). Half of each group underwent voluntary running. Food intake, running distance, body weight, lipids, inflammation markers, and atherosclerotic plaque were quantified. Two-way ANOVA tests were used to assess differences and interactions between groups. Exercised mice ran approximately 6-km per day with no difference between groups. Both groups increased food intake during exercise and there was a significant main effect of exercise F((1,44) = 9.86, p<0.01) without interaction. Diet or exercise produced significant independent effects on body weight (diet: F(1,52) = 6.85, p = 0.012; exercise: F(1,52) = 9.52, p<0.01) with no significant interaction. The combination of HP diet and exercise produced a greater decrease in total cholesterol (F(1, 46) = 7.9, p<0.01) and LDL (F(1, 46) = 7.33, p<0.01) with a large effect on the size of the interaction. HP diet and exercise independently reduced TGL and VLDL (p<0.05 and 0.001 respectively). Interleukin 6 and C-reactive protein were highest in the HF-sedentary group and were significantly reduced by exercise only in this group. Plaque accumulation in the aortic arch, a marker of cardiovascular events was reduced by the HP diet and the effect was significantly potentiated by exercise only in this group resulting in significant plaque regression (F1, 49 = 4.77, p<0.05). Conclusion: In this model exercise is beneficial to combat dyslipidemia and protect from atherosclerosis only when combined with diet.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Surgery

A Reliable Mouse Model of Hind limb Gangrene

Punam P. Parikh, Diego Castilla, Roberta M. Lassance-Soares, Hongwei Shao, Manuela Regueiro, Yan Li, Roberto Vazquez-Padron, Keith A. Webster, Zhao-Jun Liu, Omaida C. Velazquez

ANNALS OF VASCULAR SURGERY (2018)

Article Cardiac & Cardiovascular Systems

Regulation of Vascular Calcification by Growth Hormone-Releasing Hormone and Its Agonists

Jian Shen, Ning Zhang, Yi-Nuo Lin, PingPing Xiang, Xian-bao Liu, Peng-fei Shan, Xin-yang Hu, Wei Zhu, Yao-liang Tang, Keith A. Webster, Renzhi Cai, Andrew V. Schally, Jian'an Wang, Hong Yu

CIRCULATION RESEARCH (2018)

Article Cell Biology

MicroRNA-25 Protects Smooth Muscle Cells against Corticosterone-Induced Apoptosis

Bin Zhang, Gaoxing Zhang, Tianlu Wei, Zhen Yang, Wenfeng Tan, Ziqing Mo, Jinxue Liu, Dong Li, Yidong Wei, Lukun Zhang, Keith A. Webster, Jianqin Wei

OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2019)

Article Cardiac & Cardiovascular Systems

Osteopontin Promotes Left Ventricular Diastolic Dysfunction Through a Mitochondrial Pathway

Keyvan Yousefi, Camila I. Irion, Lauro M. Takeuchi, Wen Ding, Guerline Lambert, Trevor Eisenberg, Sarah Sukkar, Henk L. Granzier, Mei Methawasin, Dong Lee, Virginia S. Hahn, David A. Kass, Konstantinos E. Hatzistergos, Joshua M. Hare, Keith A. Webster, Lina A. Shehadeh

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2019)

Article Cardiac & Cardiovascular Systems

c-Kit suppresses atherosclerosis in hyperlipidemic mice

Lei Song, Zachary M. Zigmond, Laisel Martinez, Roberta M. Lassance-Soares, Alejandro E. Macias, Omaida C. Velazquez, Zhao-Jun Liu, Alghidak Salama, Keith A. Webster, Roberto Vazquez-Padron

AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2019)

Article Physiology

Nuclear Osteopontin Is a Marker of Advanced Heart Failure and Cardiac Allograft Vasculopathy: Evidence From Transplant and Retransplant Hearts

Camila Iansen Irion, Julian C. Dunkley, Krista John-Williams, Jose Manuel Condor Capcha, Serene A. Shehadeh, Andre Pinto, Matthias Loebe, Keith A. Webster, Nicolas A. Brozzi, Lina A. Shehadeh

FRONTIERS IN PHYSIOLOGY (2020)

Review Physiology

β2-Adrenergic receptor agonism as a therapeutic strategy for kidney disease

Ali Kamiar, Keyvan Yousefi, Julian C. Dunkley, Keith A. Webster, Lina A. Shehadeh

Summary: Chronic kidney disease affects approximately 14% of the global population and can lead to acute kidney injury with a high mortality rate and lack of effective treatment. beta(2)-Adrenergic receptors (beta(2)ARs) are expressed in multiple parts of the kidney and play a crucial role in regulating important cellular functions. Research is ongoing to explore the potential nephroprotective effects of activating beta(2)ARs in kidney-related diseases.

AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY (2021)

Article Cardiac & Cardiovascular Systems

Carvedilol and exercise combination therapy improves systolic but not diastolic function and reduces plasma osteopontin in Col4a3-/- Alport mice

Julian C. Dunkley, Camila I. Irion, Keyvan Yousefi, Serene A. Shehadeh, Guerline Lambert, Krista John-Williams, Keith A. Webster, Jeffrey J. Goldberger, Lina A. Shehadeh

Summary: In a mouse model of heart failure with preserved ejection fraction (HFpEF), exercise and carvedilol synergistically improved systolic function without affecting diastole. Carvedilol alone or in combination with exercise also improved kidney function. The observed improvements in cardiorenal functions were mediated at least in part by effects on serum osteopontin and related inflammatory cytokine cascades, presenting new potential therapeutic targets and approaches for HFpEF.

AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2021)

Review Biochemistry & Molecular Biology

Concurrent Physiological and Pathological Angiogenesis in Retinopathy of Prematurity and Emerging Therapies

Chang Dai, Keith A. Webster, Amit Bhatt, Hong Tian, Guanfang Su, Wei Li

Summary: Retinopathy of prematurity (ROP) is an ocular vascular disease that affects premature infants, characterized by pathological retinal neovascularization, dilated and tortuous retinal blood vessels, and retinal or vitreous hemorrhages. Current treatments include laser or cryotherapy, but there is ongoing research looking into selectively inhibiting pathological angiogenesis while promoting physiological angiogenesis in the treatment of ROP.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Review Biochemistry & Molecular Biology

Neurovascular regulation in diabetic retinopathy and emerging therapies

Liyang Ji, Hong Tian, Keith A. Webster, Wei Li

Summary: Diabetic retinopathy is the leading cause of vision loss in working adults in developed countries, now recognized as a neurovascular disorder. Disturbance of the neurovascular unit can lead to vision-threatening clinical manifestations. While VEGF inhibitors are widely used to treat DR, their limited efficacy suggests the involvement of other signaling molecules in the pathogenesis of the disease.

CELLULAR AND MOLECULAR LIFE SCIENCES (2021)

Article Biochemistry & Molecular Biology

Secretogranin III stringently regulates pathological but not physiological angiogenesis in oxygen-induced retinopathy

Chang Dai, Prabuddha Waduge, Liyang Ji, Chengchi Huang, Ye He, Hong Tian, Elizabeth Zuniga-Sanchez, Amit Bhatt, Iok-Hou Pang, Guanfang Su, Keith A. Webster, Wei Li

Summary: Secretogranin III (Scg3) is a disease-specific angiogenic factor that strictly regulates pathological angiogenesis without affecting physiological angiogenesis. The use of anti-Scg3 humanized antibody Fab (hFab) can effectively inhibit pathological angiogenesis without adverse effects, making it a potential safe and effective disease-targeted anti-angiogenic therapy.

CELLULAR AND MOLECULAR LIFE SCIENCES (2022)

Article Biotechnology & Applied Microbiology

MiR-126-HMGB1-HIF-1 Axis Regulates Endothelial Cell Inflammation during Exposure to Hypoxia-Acidosis

Jinxue Liu, Eileen Wei, Jianqin Wei, Wei Zhou, Keith A. Webster, Bin Zhang, Dong Li, Gaoxing Zhang, Yidong Wei, Yusheng Long, Xiuyu Qi, Qianhuan Zhang, Dingli Xu

Summary: The interactions between miR-126, HIF-1α, and HMGB1 play a crucial role in regulating inflammation and angiogenesis in different physiological and pathological conditions. miR-126 plays a dominant role in regulating HMGB1 and its downstream proinflammatory effectors in endothelial cells under hypoxia with concurrent acidosis, while HIF-1α expression is suppressed independently of miR-126 in these conditions. The findings suggest that the inflammatory responses of endothelial cells to hypoxia with acidosis are dynamically regulated by the interactions between hypoxia signaling, miR-126, and HIF-1α on the master regulator HMGB1.

DISEASE MARKERS (2021)

Article Biochemistry & Molecular Biology

Selectively targeting disease-restricted secretogranin III to alleviate choroidal neovascularization

Liyang Ji, Prabuddha Waduge, Lili Hao, Avinash Kaur, Wencui Wan, Yan Wu, Hong Tian, Jinsong Zhang, Keith A. Webster, Wei Li

Summary: Choroidal neovascularization (CNV), a leading cause of blindness in the elderly, is commonly treated with vascular endothelial growth factor (VEGF) inhibitors, but these therapies have limited efficacy and potential side effects. This study explores the potential of secretogranin III (Scg3) as a disease-selective angiogenic factor for the treatment of CNV. The researchers found that Scg3 binds specifically to CNV vessels and its neutralization inhibits CNV. The combination of an anti-Scg3 antibody and a VEGF inhibitor showed synergistic effects in alleviating CNV. These findings suggest that Scg3 could be a next-generation targeted therapy for CNV.

FASEB JOURNAL (2022)

Article Biochemistry & Molecular Biology

Optimal Efficacy and Safety of Humanized Anti-Scg3 Antibody to Alleviate Oxygen-Induced Retinopathy

Ye He, Hong Tian, Chang Dai, Rong Wen, Xiaorong Li, Keith A. Webster, Wei Li

Summary: The retinopathy of prematurity (ROP) is a major cause of childhood blindness, and there is an urgent need for a novel therapeutic treatment. Recent research has identified that anti-Scg3 hAb can alleviate pathological retinal neovascularization in mouse models, and it outperforms the current VEGF inhibitor aflibercept in terms of efficacy and safety.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Review Biochemistry & Molecular Biology

Secretogranin III: a diabetic retinopathy-selective angiogenic factor

Wei Li, Keith A. Webster, Michelle E. LeBlanc, Hong Tian

CELLULAR AND MOLECULAR LIFE SCIENCES (2018)

No Data Available